Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population.
Ewa SieliwonczykMaaike AlaertsEline SimonsDirk SnydersAleksandra NijakBert VandendriesscheDorien SchepersDogan AkdenizEmeline Van CraenenbroeckKatleen KnaepenLaura RabautHein HeidbuchelLut Van LaerJohan SaenenAlain J LabroBart LoeysPublished in: Orphanet journal of rare diseases (2023)
The c.1124_1127delTTCA frameshift variant shows a high prevalence in our region, despite not being confirmed as a founder mutation. This variant leads to a mild LQTS phenotype in the heterozygous state. Despite initial evidence for a gain-of-function effect based on in vitro electrophysiological assessment in CHO cells and expression of the KCNQ1 c.1124_1127delTTCA allele in patient blood cells, additional testing in iPSC-CMs showed lack of expression of the mutant allele. This suggests haploinsufficiency as the pathogenic mechanism. Nonetheless, as inter-individual differences in allele expression in (iPSC-) cardiomyocytes have not been assessed, a modifying effect on the BrS phenotype through potassium current modulation cannot be excluded.